Mahil, SK, Yates, M, Yiu, ZZN, Langan, SM, Tsakok, T, Dand, N, Mason, KJ, McAteer, H, Meynell, F, Coker, B, Vincent, A, Urmston, D, Vesty, A, Kelly, J, Lancelot, C, Moorhead, L, Bachelez, H, Capon, F, Contreras, CR, de la Cruz, C, Di Meglio, P, Gisondi, P, Jullien, D, Lambert, J, Naldi, L, Norton, S, Puig, L, Spuls, P, Torres, T, Warren, RB, Waweru, H, Weinman, J, Brown, MA, Galloway, JB, Griffiths, CM, Barker, JN, Smith, CH, PsoProtect Study Grp. Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17450. PMID:34145643. IF:9.228(Q1/1D).

Reich, K, Hansen, JB, Puig, L, Konstantinou, MP, Warren, RB. Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17433. PMID:34076919. IF:9.228(Q1/1D).

Sanchez-Velazquez, A, Bauer-Alonso, A, Estrach, T, Vega-Diez, D, Garcia-Muret, P, Haya, L, Penate, Y, Acebo, E, de Misa, RF, Blanes, M, Suh-Oh, HJ, Izu, R, Silva-Diaz, E, Sarriugarte, J, Roman-Curto, C, Botella-Estrada, R, Mateu-Puchades, A, Prieto-Torres, L, Morillas, V, Morillo, M, Sanchez-Caminero, P, Calzado, L, Perez-Ferriols, A, Perez, A, Dominguez, JD, Navedo, M, Muniesa, C, Combalia, A, Arroyo-Andres, J, Descalzo, MA, Garcia-Doval, I, Ortiz-Romero, PL. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17430. PMID:34062018. IF:9.228(Q1/1D).

Rusinol, L, Amat-Samaranch, V, Baselga, E, Puig, L, Roe, E. Prepubertal retroareolar cysts. PEDIATRIC DERMATOLOGY. 2021; 38(5)DOI:10.1111/pde.14786. PMID:34514639. IF:1.997(Q3/7D).

Speeckaert, R, Lambert, J, Puig, L, Speeckaert, M, Lapeere, H, De Schepper, S, van Geel, N. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?. DRUGS IN R&D. 2021; 21(3)DOI:10.1007/s40268-021-00349-0. PMID:34106430. IF:3.203(Q3/6D).

Iznardo, H, Vilarrasa, E, Lopez-Ferrer, A, Puig, L. Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(3)DOI:10.1111/bjd.20416. PMID:33913516. IF:11.113(Q1/1D).

Julia, A, Martinez-Mateu, SH, Domenech, E, Canete, JD, Ferrandiz, C, Tornero, J, Gisbert, JP, Fernandez-Nebro, A, Dauden, E, Barreiro-de Acosta, M, Perez, C, Queiro, R, Lopez-Longo, FJ, Carazo, JLS, Mendoza, JL, Alperi, M, Montilla, C, Venegas, JJP, Munoz, F, Castaneda, S, Lasanta, ML, Marsal, S, Fonseca, E, Rodriguez, J, Carreira, P, Garcia, V, Pinto-Tasende, JA, Puig, L, Ricart, E, Blanco, F, Gratacos, J, Blanco, R, Taboada, VM, Fernandez, E, Unamuno, P, Gonzalez, I, Garcia, FG, Sanmarti, R, Gutierrez, A, Olive, A, Estebaranz, JLL, Garcia-Planella, E, Torre-Alonso, JC, Andreu, JL, Ramirez, DM, Fernandez, B, Zamorano, MAA, de la Cueva, P, Mateu, PN, Vela, P, Vanaclocha, F, Coromines, H, Munoz, S, Nolla, JM, Herrera, E, Gonzalez, C, de la Fuente, JLM, Vera, M, Erra, A, Roig, D, Zea, A, Comas, ME, Tomas, C, Zarco, P, Pego, JM, Saro, C, Gonzalez, A, Freire, M, Garcia, A, Diez, E, Salvador, G, Diaz, C, Sanchez, S, Dominguez, AW, Mosquera, JA, Ramirez, J, Almaraz, ER, Palau, N, Tortosa, R, Lopez, M, Pluma, A, Aterido, A. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study. EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2021; 75(9)DOI:10.1038/s41430-021-00913-6. PMID:33893449. IF:4.884(Q2/4D).

Rozas-Munoz, E, Lopez-Sanchez, C, Piquero-Casals, J, Roe, E, Mir-Bonafe, JF. Papules and vesicles on the ears of a young boy. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2021; 60(8)DOI:10.1111/ijd.15336. PMID:33259059. IF:3.204(Q2/4D).

Iznardo, H, Puig, L. Dual inhibition of IL-17A and IL-17F in psoriatic disease. Therapeutic Advances in Chronic Disease. 2021; 12DOI:10.1177/20406223211037846. PMID:34408825. IF:4.970(Q2/3D).

Speeckaert, R, Lambert, J, Puig, L, Speeckaert, M, Lapeere, H, De Schepper, S, van Geel, N. Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology''. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021; 85(2)DOI:10.1016/j.jaad.2021.03.038. PMID:33744352. IF:15.487(Q1/1D).

van Straalen, KR, Tzellos, T, Guillem, P, Benhadou, F, Cuenca-Barrales, C, Daxhelet, M, Daoud, M, Efthymiou, O, Giamarellos-Bourboulis, EJ, Jemec, GBE, Katoulis, AC, Koenig, A, Lazaridou, E, Marzano, AV, Matusiak, L, Molina-Leyva, A, Moltrasio, C, Pinter, A, Potenza, C, Romani, J, Saunte, DM, Skroza, N, Stergianou, D, Szepietowski, J, Trigoni, A, Vilarrasa, E, van der Zee, HH. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2021; 85(2)DOI:10.1016/j.jaad.2020.12.089. PMID:33484766. IF:15.487(Q1/1D).

Puig, L, Bakulev, AL, Kokhan, MM, Samtsov, AV, Khairutdinov, VR, Morozova, MA, Zolkin, NA, Kuryshev, IV, Petrov, AN, Artemeva, AV, Zinkina-Orikhan, AV. Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00554-4. PMID:34060012. IF:3.661(Q2/3D).

Lambert, J, Hansen, JB, Sohrt, A, Puig, L. Dermatology Life Quality Index in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab or Ustekinumab. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00545-5. PMID:33988818. IF:3.661(Q2/3D).

Papp, KA, Soliman, AM, Done, N, Carley, C, Wirtz, EL, Puig, L. Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model. Dermatology and Therapy. 2021; 11(4)DOI:10.1007/s13555-021-00550-8. PMID:34019229. IF:3.661(Q2/3D).

Garcia-Melendo, C, Cubiro, X, Puig, L. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses. Actas Dermo-Sifiliograficas. 2021; 112(7)DOI:10.1016/j.ad.2020.12.006. PMID:34030992. IF:(Q/D).

Vidal, S, Puig, L, Carrascosa-Carrillo, JM, Gonzalez-Cantero, A, Ruiz-Carrascosa, JC, Velasco-Pastor, AM. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(13)DOI:10.3390/ijms22136740. PMID:34201664. IF:6.208(Q1/3D).

Garcia-Melendo, C, Roe, E, Rodriguez-Santiago, B, Amat-Samaranch, V, Cubiro, X, Puig, L, Boronat, S. A case report of PHF6 mosaicism: Beyond the classic Borjeson-Forssman-Lehmann syndrome. PEDIATRIC DERMATOLOGY. 2021; 38(4)DOI:10.1111/pde.14636. PMID:34041787. IF:1.997(Q3/7D).

Carmona-Rocha, E, Iznardo, H, Puig, L. Retiform purpura in an 80-year-old woman. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2022; 61(10)DOI:10.1111/ijd.16120. PMID:35106756. IF:3.600(Q1/3D).

Richard, MA, Paul, C, Nijsten, T, Gisondi, P, Salavastru, C, Taieb, C, Trakatelli, M, Puig, L, Stratigos, A, EADV Burden Skin Dis Project Team. Prevalence of most common skin diseases in Europe: a population-based study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022; 36(7)DOI:10.1111/jdv.18050. PMID:35274366. IF:9.200(Q1/1D).

Lebwohl, M, Soliman, AM, Yang, HB, Wang, J, Freimark, J, Puig, L. Impact of PASI response on work productivity and the effect of risankizumab on indirect costs using machine learning in patients with moderate-to-severe psoriasis. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(4)DOI:10.1080/09546634.2021.1919287. PMID:33899655. IF:2.900(Q2/4D).